Clinical Trial Update: A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A

View source ↗

Summary

Takeda is conducting a recruiting trial to evaluate susoctocog alfa in participants with acquired hemophilia A. This entry shows the study status as RECRUITING …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hemophilia

Drugs mentioned

• Susoctocog alfa (susoctocog alfa)

Snippet

Sponsor: Takeda | Conditions: Acquired Hemophilia A | Status: RECRUITING